# FDA 483 - Melody L. Stone, M.D. - June 06, 2023

Source: https://www.keypedia.com/records/483/melody-l-stone-md/fbe0b093-4c59-4ac2-b0ab-68475ae9d60c

> FDA 483 for Melody L. Stone, M.D. on June 06, 2023. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Melody L. Stone, M.D.
- Inspection Date: 2023-06-06
- Product Type: drugs
- Office Name: Division of Human and Animal Food Operations - West II
- Summary: An FDA inspection of Melody Stone, M.D., a clinical investigator in Saint Joseph, MO, revealed a significant issue with adherence to an investigational plan. The investigator failed to complete required physical examinations for multiple subjects at specified time points during Protocol CAIN457M2301. This indicates a lack of compliance with study protocols.

## Related Officers

- [Carmen Y. Fisher](https://www.keypedia.com/people/carmen-y-fisher/d41b9f1a-1a29-4b1c-bd64-acedde50302a)

Company: https://www.keypedia.com/companies/melody-l-stone-md/d97603d8-646e-405b-92fe-9bc31a133728

Office: https://www.keypedia.com/offices/division-of-human-and-animal-food-operations-west-ii/8851d151-0390-4d17-be66-fd86d12aa6b8
